The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
KAYS · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | TDOC | KAYS | NPCE | XGN |
|---|---|---|---|---|
| Moat Score (0–100) | 44 (highest) | 44 (highest) | 44 (highest) | 44 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 51 | 10 | 70 (highest) | 52 |
| Pricing power | 98 | 69 | 100 (highest) | 89 |
| Returns on capital | 0 (highest) | — | 0 (highest) | 0 (highest) |
| Balance-sheet safety | 28 | 55 (highest) | 28 | 55 (highest) |
| Capital allocation | 44 (highest) | 44 (highest) | 24 | 24 |
| No price data | No price data | No price data | No price data | |
| Market cap | $1.6B | $12439 | $497M | $107M |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2025 | FY2024 | FY2025 | FY2025 |